Evidence map›Paper›PMID 36710363›Full record

ArticleAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology2023

Simulation-based education to improve management of refractory anaphylaxis in an allergy clinic.

Ana M Copaescu, Francois Graham, Nathalie Nadon, Rémi Gagnon, Arnaud Robitaille, Mohamed Badawy, David Claveau, Anne Des Roches, Jean Paradis, Matthieu Vincent and 1 more

Open access · goldAbstract read
In one paragraph

Article in Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Preparing Allergists to Practice in 2050 Using Artificial Intelligence.The journal of allergy and clinical immunology. In practice · 2025
    Review
  2. Article
  3. Article
  4. Management of Refractory Anaphylaxis: An Overview of Current Guidelines.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2024
    Review
  5. How to Define and Manage Low-Risk Drug Allergy Labels.The journal of allergy and clinical immunology. In practice · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Ana M CopaescuDepartment of Medicine, Allergy-Immunology Division, Université de Montréal, Montreal, QC, Canada. ana.copaescu@gmail.com.ORCID http://orcid.org/0000-0002-9183-5032
Francois GrahamDepartment of Medicine, Allergy-Immunology Division, Université de Montréal, Montreal, QC, Canada.
Nathalie NadonLearning and Simulation Center, CHUM Academy, Montreal, QC, Canada.
Rémi GagnonDepartment of Medicine, Allergy-Immunology Division, Université Laval, Quebec, QC, Canada.
Arnaud RobitailleDepartment of Anesthesiology, Université de Montréal, Montreal, QC, Canada.
Mohamed BadawyDepartment of Anesthesiology, Montreal Neurological Institute and Hospital, Montreal, QC, Canada.
David ClaveauDepartment of Emergency, Université de Montréal, Montreal, QC, Canada.
Anne Des RochesDepartment of Medicine, Allergy-Immunology Division, Université de Montréal, Montreal, QC, Canada.
Jean ParadisDepartment of Medicine, Allergy-Immunology Division, Université de Montréal, Montreal, QC, Canada.
Matthieu VincentDepartment of Emergency, Hôpital Charles-Le Moyne, Université de Sherbrooke, Greenfield Park, QC, Canada.
Philippe BéginDepartment of Medicine, Allergy-Immunology Division, Université de Montréal, Montreal, QC, Canada.
Université de Montréal · CAMcGill University Health Centre · CAMontreal Neurological Institute and Hospital · CAUniversité de Sherbrooke · CAUniversité Laval · CA

Funding

Fonds de Recherche du Québec - Santé 281662
6 · The paper itself

Abstract

backgroundHigh-fidelity simulations based on real-life clinical scenarios have frequently been used to improve patient care, knowledge and teamwork in the acute care setting. Still, they are seldom included in the allergy-immunology curriculum or continuous medical education. Our main goal was to assess if critical care simulations in allergy improved performance in the clinical setting.

methodsAdvanced anaphylaxis scenarios were designed by a panel of emergency, intensive care unit, anesthesiology and allergy-immunology specialists and then adapted for the adult allergy clinic setting. This simulation activity included a first part in the high-fidelity simulation-training laboratory and a second at the adult allergy clinic involving actors and a high-fidelity mannequin. Participants filled out a questionnaire, and qualitative interviews were performed with staff after they had managed cases of refractory anaphylaxis.

resultsFour nurses, seven allergy-immunology fellows and six allergy/immunologists underwent the simulation. Questionnaires showed a perceived improvement in aspects of crisis and anaphylaxis management. The in-situ simulation revealed gaps in the process, which were subsequently resolved. Qualitative interviews with participants revealed a more rapid and orderly response and improved confidence in their abilities and that of their colleagues to manage anaphylaxis.

conclusionHigh-fidelity simulations can improve the management of anaphylaxis in the allergy clinic and team confidence. This activity was instrumental in reducing staff reluctance to perform high-risk challenges in the ambulatory setting, thus lifting a critical barrier for implementing oral immunotherapy at our adult center.

Indexed as

Allergic emergenciesAllergy clinicAmbulatory settingAnaphylaxisAnaphylaxis managementHigh fidelity simulation based-learningMedical educationTeamwork

Identifiers

PMID36710363
PMCPMC9885607
OpenAlexW4318427144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.